CDC reports on influenza vaccination coverage of healthcare professionals in
2015–2016
CDC published
Influenza Vaccination Coverage Among Health Care Personnel—United States,
2015–16 Influenza Season in the
September 30 issue of MMWR
(pages 1026–31). A summary made available to the press is reprinted below.
The Advisory Committee on Immunization Practices (ACIP) recommends that all
health-care personnel (HCP) be vaccinated annually against influenza.
Vaccination of HCP can reduce influenza-related morbidity and mortality among
HCP and their patients. Overall, 79.0% of HCP reported receiving an influenza
vaccination in the 2015–16 season, similar to the 77.3% coverage among HCP
reported in the 2014–15 season. Vaccination coverage continues to be higher
among HCP working in hospitals (91.2%) and lower among HCP working in
ambulatory (79.8%) and long-term care settings (69.2%); however, long-term
care settings were the only setting in which coverage increased in 2015–16
compared with 2014–15 (an increase of 5.3 percentage points). Coverage
continues to be highest among physicians (95.6%) and lowest among assistants
and aides (64.1%), and highest among HCP who were required by their employer
to be vaccinated (96.5%). Among HCP working in settings where vaccination was
neither required, promoted, nor offered on site, vaccination coverage
continues to be low (44.9%).
Related Links
Back to top
Final 2015–16 influenza vaccination coverage estimates reported in MMWR
CDC published Announcement:
Final 2015–16 Influenza Vaccination Coverage Estimates for Selected Local
Areas, States, and the United States Available Online in the September 30 issue of MMWR (page 1041). An excerpt is reprinted below.
Final 2015–16 influenza season vaccination coverage estimates are available
online at FluVaxView (http://www.cdc.gov/flu/fluvaxview/).
The online information includes estimates of the cumulative percentage of
persons vaccinated through the end of each month during July 2015–May 2016,
for selected local areas, states, and regions as designated by the U.S.
Department of Health and Human Services, and the United States overall.
Back to top
CDC reports on measles outbreak in Shelby County, Tennessee
CDC published Notes from the Field:
Measles Outbreak of Unknown Source—Shelby County, Tennessee, April–May 2016 in the September 30 issue of MMWR
(pages 1039–1040). Some excerpts from the article are reprinted below.
On April 15, 2016, local public health officials in Shelby County, Tennessee, were notified of a positive measles immunoglobulin M (IgM) test for a male aged 18 months (patient A). On April 18, 2016, a second positive measles IgM test was reported for a man aged 50 years (patient B). Both patients had rash onset on April 9, 2016. The Shelby County Health Department initiated an investigation, and confirmatory testing for measles virus on oropharyngeal swabs by polymerase chain reaction (PCR) at CDC was positive for both patients. On April 21, 2016, public health officials were notified of a third suspected measles case in a female aged 7 months (patient C) who had developed a rash on April 14; PCR testing was positive. Genotyping conducted at CDC identified genotype B3 measles virus in all three cases. Genotype B3 is known to be circulating globally and has previously been associated with imported cases in the United States...
This outbreak, with three epidemiologically distinct chains of transmission and no identified common source, highlights the importance of high 2-dose MMR vaccination coverage among vaccine-eligible persons and the need for ongoing, vigilant surveillance for measles virus in the United States. Clinical providers and public health officials should maintain a high index of suspicion for measles because delayed recognition and delayed reporting to public health officials can lead to a rapid propagation of cases and difficulty in tracking epidemiologic links during investigations. One patient in this outbreak was admitted to a tertiary care hospital for 72 hours, and although measles IgM testing was ordered, the patient was not placed in airborne isolation. The provider thought a measles diagnosis was unlikely because no documented measles cases had been reported in Shelby County for >10 years and vaccination rates in the area are generally high (approximately 90%).
As demonstrated in this outbreak, a lack of international travel and absence of recent measles cases in the community can provide false reassurance, and it is important that patients with clinically compatible illness and an uncertain vaccination history be evaluated for measles. This outbreak serves as a reminder that certain communities are susceptible to measles outbreaks; however, risks for these outbreaks can be mitigated through prompt identification of potential cases with early notification of public health officials to suspected cases, rapid public health response, and maintenance of high 2-dose MMR vaccination coverage in the community. In addition, all health care workers born during or after 1957 should receive 2 doses of MMR vaccine and ensure that their immunization records are easily accessible for confirmation.
Back to top
PAHO/WHO announces measles elimination in the Americas
The Pan American Health Organization (PAHO), the Regional Office for the Americas of the World Health Organization, announced the elimination of measles in the Americas. An excerpt from their press release, Region of the Americas is declared free of measles, is reprinted below.
The Region of the Americas is the first in the world to have eliminated measles, a viral disease that can cause severe health problems, including pneumonia, brain swelling and even death. This achievement culminates a 22-year effort involving mass vaccination against measles, mumps and rubella throughout the Americas.
The declaration of measles’ elimination was made by the International Expert
Committee for Documenting and Verifying Measles, Rubella, and Congenital
Rubella Syndrome Elimination in the Americas. The announcement came during the
55th Directing Council of the Pan American Health Organization/World Health
Organization (PAHO/WHO), which is currently underway and is being attended by
ministers of Health from throughout the Americas.
Related Links
Back to top
NFID releases summary of September 29 news conference about influenza and pneumococcal disease
On September 29, the National Foundation for Infectious Diseases (NFID) hosted the 2016 Influenza/ Pneumococcal News Conference in collaboration with CDC and other leading medical and public health groups who rallied together to show their strong support for influenza immunization. The event served to communicate critical messages, including a call to action for everyone to get vaccinated. Two paragraphs from a related September 29 press release are reprinted below.
With influenza (flu) vaccine readily available and sufficient doses expected throughout the season, the National Foundation for Infectious Diseases (NFID), along with public health and medical organizations urge the public and healthcare professionals to follow the Centers for Disease Control and Prevention (CDC) recommendation for everyone age six months and older to be vaccinated against influenza each year.
Influenza vaccination coverage across the entire U.S. population was 45.6
percent, down by 1.5 percentage points from the previous season. The largest
coverage decreases were seen among older people with a drop of 3.4 percentage
points to 43.6 percent among people 50 to 64 years old and a drop of 3.3
percentage points to 63.4 percent among people 65 years and older. The highest
influenza vaccination coverage among the public during the 2015–2016 season
was among children age 6 months through 23 months. At 75 percent, this is the
only group of people that exceeds the national public health goals of 70
percent vaccination coverage. Coverage of 46 percent among the public means
about 144 million people received a flu vaccine last season in the U.S.
Related Links
Back to top
CDC’s “Parents Guide to Childhood Immunizations” wins a 2016 National Health
Information Award
CDC's Parents' Guide to Childhood Immunizations
won a 2016 National Health Information Award. The Parents' Guide helps parents
and caregivers learn about the role vaccines play in helping keep children
healthy. The color booklet includes a glossary and list of resources and is
illustrated with children’s artwork.
The book is available to download in full or by chapter on the Parents' Guide to Childhood Immunizations web section. Information on ordering print editions is available on the site as well.
Related Link
Back to top
Join the Hepatitis B Foundation as part of their Hepatitis B Storytelling Project
The Hepatitis B Storytelling Project is a project to make the real voices of everyday people living with or affected by Hepatitis B a key ingredient of the Hepatitis B Foundation's prevention and advocacy efforts. The Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations (AAPCHO) are partnering with StoryCenter to launch the project.
The Hepatitis B Foundation is committed to representing a diversity of people and perspectives with this project. They're looking for women and men age 18 or older who are willing to attend a four-day digital storytelling workshop, share a unique, personal story as a short video, and become a champion in their local communities to publicly share the collection of stories. To learn more about the project, or if interested in participating in the digital storytelling workshop, please visit the project website and complete the storyteller information packet.
Email Kate Moraras at the Hepatitis B Foundation with any questions.
Back to top
Centers for Medicare and Medicaid Services adds reimbursement for hepatitis B screening
The Centers for Medicare and Medicaid Services recently issued its final decision regarding coverage of hepatitis B screening, titled Decision Memo for Screening for Hepatitis B Virus (HBV) Infection. An excerpt from the decision is printed below.
The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to conclude that screening for Hepatitis B Virus (HBV) infection, consistent with the grade A and B recommendations by the U.S. Preventive Services Task Force (USPSTF), is reasonable and necessary for the prevention or early detection of an illness or disability and is appropriate for individuals entitled to benefits under Part A or enrolled under Part B.
Back to top
VACCINE INFORMATION STATEMENTS
IAC posts nine translations of the Hepatitis B VIS
IAC recently posted the following translations of the Hepatitis B VIS, dated 7/20/2016:
Related Links
Back to top
IAC posts nine translations of the Serogroup B Meningococcal (MenB) VIS
IAC recently posted the following translations of the Meningococcal (MenB) VIS, dated 8/9/2016:
Related Links
Back to top
Adult Immunization Resource Guide now available online from Association of Immunization Managers
The Association of Immunization Managers (AIM) recently released its publication
Adult Immunization Resource Guide. An excerpt from
AIM's announcement of its release is reprinted below.
The Adult Immunization Resource Guide is meant to provide examples of programmatic activities and relevant resources for immunization programs to use to increase adult immunization rates in their jurisdiction. The Guide includes chapters on IIS, reaching adults where they live and work, engaging the public and providers, reaching special populations like those at high risk and pregnant women, as well as collaborations with pharmacists and reaching the uninsured.
Related Links
Back to top
CDC offers digital media toolkit for influenza season
CDC recently released its digital media toolkit
for the 2016–17 influenza season. CDC relies heavily on its network of partner organizations to promote its messages and activate communities to get vaccinated. To assist in your efforts to help spread the word about the serious complications influenza can cause and the importance of vaccination, this guide provides details for events/activities, sample social media and newsletter content, website badges, and online resources.
Related Links
Back to top
“Talking About Vaccines with Dr. Paul Offit” DVDs available for purchase through
VEC
Talking About Vaccines with Dr. Paul Offit DVDs are available for purchase on the Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia's website. This series of short videos features Dr. Paul Offit answering common questions about vaccines. The videos are available on DVDs in a looped format and are available for purchase by healthcare providers.
Practices and clinics looking for something educational (and interesting) to play in the waiting room should consider purchasing these DVDs. You can check out the videos on YouTube.
Back to top
JOURNAL ARTICLES AND NEWSLETTERS
Medical Assistants Resources and Training on Immunization (MARTi) releases newsletter on influenza
Medical Assistants Resources and Training on Immunization (MARTi) provides immunization-related information and links to training opportunities for medical assistants. MARTi just released a
newsletter that focuses on the 2016–17 influenza season.
MARTi is funded through a cooperative agreement between CDC and the Association for Prevention Teaching and Research (APTR).
Visit the MARTi website at www.marti-us.org and be sure to recommend it to the medical assistants with whom you work.
Related Links
Back to top
EDUCATION AND TRAINING
NFID to offer webinar, “Reducing the Burden of Pneumococcal Infection through
Vaccination,” on October 11
Back to top
CONFERENCES AND MEETINGS
2017 Annual Conference on Vaccine Research to be held April 24–26 in
Baltimore; abstract submission ends December 5
The
National Foundation for Infectious Diseases (NFID) is hosting its
Conference on Vaccine Research
in Baltimore, MD, on April 24–26, 2017. Now in its 20th year, the Annual
Conference on Vaccine Research (ACVR) provides high-quality, current reports
of scientific progress and best practices featured in both invited
presentations and submitted oral abstracts and posters.
Abstract submissions for oral or poster presentations at the 2017 Annual Conference on Vaccine Research will be accepted until 11:59 p.m. (ET), December 5, 2016.
Related Link
ASK THE EXPERTS
Question of the Week
Mom comes in with her 19-month-old. She reports that her (the mother’s)
sibling has a history of a severe reaction to pertussis vaccine in the mid
1990s. Now mom is reluctant to give her child pertussis vaccine although the
child received Pediarix (DTaP-HepB-IPV, GlaxoSmithKline) 2 months ago without
incident. Should we be concerned about the mother’s family history of a severe
reaction to pertussis vaccine?
A family history of a neurologic disorder or reaction to a pertussis-containing vaccine is not a contraindication to vaccination of this child. The child should receive additional DTaP doses as indicated in the catchup schedule.
About IAC's Question of the Week
Each week, IAC Express highlights a new, topical, or
important-to-reiterate Q&A. This feature is a cooperative venture between IAC
and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization
education, chooses a new Q&A to feature every week from a set of Q&As prepared
by experts at CDC’s National Center for Immunization and Respiratory Diseases.
We hope you enjoy this feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.
If you have a question for the CDC immunization experts, you can email them directly at nipinfo@cdc.gov. There is no charge for this service.
Related Links
Back to top